Free tool
FAERS Monitor: Nitrolingual
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018705 or its brand name (Nitrolingual, Nitroglycerin). Reports on generic versions are filed under their own applications.
Reports
42,231
Serious
34,551
82% of reports
Hospitalization
20,189
Death reported
5,606
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea3,616
- pain3,221
- fatigue2,922
- myocardial infarction2,820
- nausea2,790
- dizziness2,512
- fall2,502
- chest pain2,486
- drug ineffective2,407
- headache2,256
- diarrhoea2,220
- hypotension2,073
- asthenia1,981
- renal failure1,968
- anxiety1,814
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 962 |
| 2005 | 1,094 |
| 2006 | 924 |
| 2007 | 712 |
| 2008 | 929 |
| 2009 | 1,254 |
| 2010 | 1,415 |
| 2011 | 2,304 |
| 2012 | 1,749 |
| 2013 | 887 |
| 2014 | 2,458 |
| 2015 | 1,505 |
| 2016 | 1,737 |
| 2017 | 1,805 |
| 2018 | 2,223 |
| 2019 | 2,444 |
| 2020 | 2,258 |
| 2021 | 2,287 |
| 2022 | 2,935 |
| 2023 | 2,904 |
| 2024 | 2,858 |
| 2025 | 2,755 |
| 2026 | 1,828 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,928 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| myocardial infarctionSignal | 2,820 | 8.2 | 7.9 | 17,585 |
| renal failureSignal | 1,968 | 7.5 | 7.2 | 10,941 |
| chest painSignal | 2,486 | 6.8 | 6.5 | 12,144 |
| hypotensionSignal | 2,073 | 5.2 | 5.0 | 7,003 |
| fallSignal | 2,502 | 3.8 | 3.6 | 5,120 |
| dyspnoeaSignal | 3,616 | 3.2 | 3.1 | 5,567 |
| anxietySignal | 1,814 | 3.2 | 3.0 | 2,742 |
| astheniaSignal | 1,981 | 2.6 | 2.5 | 2,030 |
| painSignal | 3,221 | 2.6 | 2.5 | 3,304 |
| dizzinessSignal | 2,512 | 2.5 | 2.4 | 2,337 |
| fatigue | 2,922 | 1.9 | 1.8 | 1,228 |
| headache | 2,256 | 1.8 | 1.7 | 815 |
| nausea | 2,790 | 1.8 | 1.7 | 944 |
| diarrhoea | 2,220 | 1.7 | 1.6 | 680 |
| drug ineffective | 2,407 | 0.9 | 0.9 | 23 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.